谷歌浏览器插件
订阅小程序
在清言上使用

Safety and Efficacy Data for Combined Checkpoint Inhibition with Ipilimumab (ipi) and Nivolumab (nivo) As Consolidation Following Autologous Stem Cell Transplantation (ASCT) for High-Risk Hematological Malignancies — CPIT-001 Trial

Blood(2018)

引用 11|浏览27
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要